Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Skin Neoplasms 1Sarcoma, Kaposi 1Sarcoma 1Neoplasms 1Muscle Neoplasms 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Zidovudine 10Doxorubicin 10Vincristine 7Bleomycin 7Liposomes 5Interferon alpha-2 5tecogalan 4Etoposide 3sargramostim 2pomalidomide 2liposomal doxorubicin 2interferon alfa-n1 2Valganciclovir 2Ritonavir 2Paclitaxel 2Nivolumab 2Mitoxantrone 2Didanosine 2vesnarinone 1tocilizumab 1tin etiopurpurin 1abemaciclib 1Zalcitabine 1Tumor Necrosis Factor-alpha 1Sorafenib 1Semaxinib 1Ro 24-7429 1O-(Chloroacetylcarbamoyl)fumagillol 1Nevirapine 1Muromonab-CD3 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Tumor Necrosis Factor-alpha × Sarcoma × Clear all
NCT00002262 2005-06-24

A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma

NIH AIDS Clinical Trials Information Service

Phase 1 Completed
DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡